AirSculpt Technologies

AIRS

Market cap $183M

MIAMI BEACH, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 2nd, 2026, by AirSculpt Technologies, Inc. (NASDAQ:AIRS), please note that the Company determined that a one-time non-cash adjustment related to the closure of its London facility was inaccurate in the calculation of Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income. The updated release reflects the updated figures.

AirSculpt Technologies, Inc. (AIRS) Q4 2025 Earnings Call Transcript

MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2025.

MIAMI BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report fourth quarter and fiscal year 2025 financial results before market open on Thursday, April 2, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.

AirSculpt Technologies, Inc. remains a Buy after a 70% stock decline, due to attractive valuation and recent buying volume. AIRS faces near-term revenue softness and must balance cost-cutting with growth initiatives, especially targeting profitable GLP-1 user segments. The company's high average ticket price (~$14k) and lack of a clear moat raise questions about long-term scalability amid inflation risks.

SAN DIEGO, March 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of AirSculpt Technologies, Inc. (NASDAQ: AIRS). The investigation focuses on AirSculpt Technologies executive officers and whether investor losses may be recovered under federal securities laws.

Preliminary Fiscal Year 2025 Revenue of $151.8 Million Refreshed Marketing Strategy Delivers Positive Same-Store Sales in February 2026 Strong Balance Sheet and Enhanced Liquidity MIAMI BEACH, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced that it expects to file a Form 12b-25 with the U.S. Securities and Exchange Commission (the “SEC”) on or about March 16, 2026, providing the Company a 15-day extension to file its annual report for the fiscal year ended December 31, 2025 on Form 10-K (the “Annual Report”).

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.

AirSculpt Technologies, Inc. ( AIRS ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Yogesh Jashnani - CEO & Director Dennis Dean - Chief Financial Officer Conference Call Participants Allison Malkin - ICR Inc. Marco Criscuolo - Nephron Research LLC Sam Eiber - BTIG, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen and welcome to the AirSculpt Technologies, Inc. Third Quarter 2025 Earnings Call. [Operator Instructions] Please note that this event is being recorded.